Cancer research powerhouse coming to London
24 Oct 2018 by Evoluted New Media
Cancer Research UK is aiming to establish a biotherapeutics powerhouse in London.
The Cancer Research UK City of London Centre has a unique research focus, with the view that biotherapeutics will become vitally important in future cancer treatments. They aim to attract millions in capital investment. The centre will boost the biotechnology economy in London as new companies are formed, and industry partners move in to translate the most promising discoveries into marketable therapies.
Biotherapeutics are any type of treatment that is produced by - or involve - living cells. These therapies are based on biological processes in cells, which we can engineer to help fight cancer. Examples include therapeutic antibodies, cell based therapies, vaccines and gene therapies.
The work at CRUK is divided into three distinct programmes, which have the shared goal of better treatments for all cancers, including childhood cancers, and developing future leaders in cancer research.
The focus of programme 1 is developing new biological therapies. Programme 2 looks at how we can combine biotherapeutics with other methods to maximise the effects of treatment. Finally, programme 3 will focus on the evolution of cancer and how targeted biotherapies can be used to overcome rapid changes in tumour genetics.
